SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-20-000123
Filing Date
2020-05-14
Accepted
2020-05-14 14:24:07
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q klfe033120form10q.htm 10-Q 648464
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12642
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12191
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5422
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 5502
  Complete submission text file 0001607062-20-000123.txt   2746986

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE klfe-20200331.xml EX-101.INS 327858
7 XBRL SCHEMA FILE klfe-20200331.xsd EX-101.SCH 33362
8 XBRL CALCULATION FILE klfe-20200331_cal.xml EX-101.CAL 46801
9 XBRL DEFINITION FILE klfe-20200331_def.xml EX-101.DEF 151397
10 XBRL LABEL FILE klfe-20200331_lab.xml EX-101.LAB 201292
11 XBRL PRESENTATION FILE klfe-20200331_pre.xml EX-101.PRE 209540
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 858-883-2642
Kannalife Inc (Filer) CIK: 0001615999 (see all company filings)

IRS No.: 462645343 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55657 | Film No.: 20876975
SIC: 2834 Pharmaceutical Preparations